Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 10:19 PM
Ignite Modification Date:
2025-12-26 @ 10:19 PM
NCT ID:
NCT02705612
Eligibility Criteria:
Inclusion Criteria:
* 18 Years to 70 Years，female
* Histological diagnosis of squamous cell carcinoma of cervix, FIGO stage IIB-IVA,with diameter 4-6 cm, without distant metastasis.
* no chance of surgery confirmed by more than two deputy chief doctors of gynecology.
* Moderate or high expression of EGFR
* The function of main organ is normal, including blood, heart, lung, liver, and kidney. Without history of hypertension, stroke. Blood pressure is normal before treatment.
* WBC≥3.5×10E9/L，ANC≥1.5×10E9/L；HB≥90g/L，PLT≥100×10E9/L
* ALT, AST and Cr below 1.5 times of normal level
* Willing to accept treatment
* Ability to comply with trial requirements KPS≥70
Exclusion Criteria:
* Evidence of distance metastasis
* Impossible to measure the diameter of tumor, or the tumor is too huge (diameter\>6cm)
* Couldn't examine with pelvic MRI due to a variety of reasons
* Used to treat with radiotherapy chemotherapy or molecular target therapy and immune therapy
* Diagnosed with another malignant tumor in 5 years
* Used to be a volunteer of other clinical trial.
* Used to be allergic reaction with grade 3 or 4 degree to any experimental drugs
* Severe medical history of lung ,liver, kidney or heart.
* Active infection in any part of the whole body.
* Examination results showed radiotherapy contraindications
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT02705612
Study Brief:
Protocol Section:
NCT02705612